论文信息 - Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.

Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.

Atrial fibrillation in the Wolff-Parkinson-White syndrome may be life-threatening because of the extremely rapid ventricular rates that can occur over the accessory pathway. An 18-year-old man with Wolff-Parkinson-White (type B) syndrome developed episodes of syncope due to atrial fibrillation. In studies during hospitalization the administration of lidocaine immediately slowed the ventricular response by abolishing antegrade conduction over the accessory pathway. The role of lidocaine and other antiarrhythmic drugs in the management of arrhythmias in the Wolff-Parkinson-White syndrome is discussed.

M. Josephson | J. Kastor | J. G. Kitchen

[1] H. Wellens,et al. Effect of Procaine Amide, Quinidine, and Ajmaline in the Wolff‐Parkinson‐White Syndrome , 1974, Circulation.

[2] A. Castellanos,et al. Factors regulating ventricular rates during atrial flutter and fibrillation in pre-excitation (Wolff-Parkinson-White) syndrome. , 1973, British heart journal.

[3] H. Wellens,et al. Effect of Digitalis on Atrioventricular Conduction and Circus‐Movement Tachycardias in Patients with Wolff‐Parkinson‐White Syndrome , 1973 .

[4] K. Rosen,et al. Effects of lidocaine and propranolol on the normal and anomalous pathways in patients with preexcitation. , 1972, The American journal of cardiology.

[5] L. Dreifus,et al. Ventricular Fibrillation: A Possible Mechanism of Sudden Death in Patients with Wolff‐Parkinson‐White Syndrome , 1971, Circulation.

[6] M. A. Kaplan,et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1969, The American journal of cardiology.

[7] B. B. Okel. The Wolff-Parkinson-White syndrome. Report of a case with fatal arrhythmia and autopsy findings of myocarditis, interatrial lipomatous hypertrophy, and prominent right moderator band. , 1968, American heart journal.